Concentrix reports Q4 EPS $3.26, consensus $3.01

Reports Q4 revenue $2.45B, consensus $2.44B. “We continue to achieve strong results across key areas of growth in our business while repurchasing shares, reducing our leverage and supporting our dividend,” said Chris Caldwell, Concentrix (CNXC) President and CEO. “Strategically, we continue to execute our plan for growth and market expansion while delivering value to shareholders. We’ve seen our investments in our GenAI product suite generate more than a dozen wins only weeks after launch. And we continue to secure large, transformative client wins that leverage our unique technology and service capabilities to fuel our clients’ success. Entering 2025, we are delighted with our strategic position and our opportunities for ongoing growth, margin and free cash flow.”